# Edwards Lifesciences Corp: Form 8-K, filed Feb 6, 2024

- Company: [Edwards Lifesciences Corp](/companies/ew.md) (CIK 1099800)
- Form: 8-K
- Filed: 2024-02-06
- Accepted by EDGAR: Feb 6, 2024, 16:23 ET
- Period: 2024-02-06
- Accession: 0001099800-24-000002
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1099800/000109980024000002/ew-20240206.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1099800/000109980024000002/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1099800/000109980024000002/ew-20240206.htm

Filed Feb 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001099800-24-000002. Last ingested by Listed: Nov 4, 2026, 17:33 ET. No prices; not investment advice.
